Skip to content
- FLABRA, frontline approach for BRCA testing in an ovarian cancer population: a Latin America epidemiologic study.
- Giornelli G, Gallardo D, Hegg R, Abuin GG, La Vega M, Lim-Law M, Caceres V, Trujillo L, Pilar Estevez-Diz MD, Pacheco C, Sganga L, Goncalves S.
- Future Oncol. 2021 Jan 8. doi: 10.2217/fon-2020-1152. Epub ahead of print.
- Modulation of Early Mitotic Inhibitor 1 (EMI1) depletion on the sensitivity of PARP inhibitors in BRCA1 mutated triple-negative breast cancer cells.
- Moustafa D, Elwahed MRA, Elsaid HH, Parvin JD.
- PLoS One. 2021 Jan 7;16(1):e0235025. doi: 10.1371/journal.pone.0235025.
- Sharing Genetic Test Results with Family Members of BRCA, PALB2, CHEK2, and ATM Carriers.
- Dean M, Tezak AL, Johnson S, Pierce JK, Weidner A, Clouse K, Pal T, Cragune D.
- Patient Educ Couns. 2021 Jan 5:S0738-3991(20)306832. doi: 10.1016/j.pec.2020.12.019. Epub ahead of print.